B-cell lymphoma epidemiology and demographics: Difference between revisions
Adnan Ezici (talk | contribs) No edit summary |
Adnan Ezici (talk | contribs) No edit summary |
||
| Line 13: | Line 13: | ||
In year 2018, the mortality rate of [[non-Hodgkin lymphoma]] is approximately 5.1/100,000.<ref name="pmid33573146">{{cite journal |vauthors=Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P |title=Epidemiology of Non-Hodgkin's Lymphoma |journal=Med Sci (Basel) |volume=9 |issue=1 |pages= |date=January 2021 |pmid=33573146 |pmc=7930980 |doi=10.3390/medsci9010005 |url=}}</ref> In year 2017, the mortality rate of [[Hodgkin's lymphoma]] is approximately 0.41/100,000.<ref name="pmid31640759">{{cite journal |vauthors=Zhou L, Deng Y, Li N, Zheng Y, Tian T, Zhai Z, Yang S, Hao Q, Wu Y, Song D, Zhang D, Lyu J, Dai Z |title=Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study |journal=J Hematol Oncol |volume=12 |issue=1 |pages=107 |date=October 2019 |pmid=31640759 |pmc=6805485 |doi=10.1186/s13045-019-0799-1 |url=}}</ref> | In year 2018, the mortality rate of [[non-Hodgkin lymphoma]] is approximately 5.1/100,000.<ref name="pmid33573146">{{cite journal |vauthors=Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P |title=Epidemiology of Non-Hodgkin's Lymphoma |journal=Med Sci (Basel) |volume=9 |issue=1 |pages= |date=January 2021 |pmid=33573146 |pmc=7930980 |doi=10.3390/medsci9010005 |url=}}</ref> In year 2017, the mortality rate of [[Hodgkin's lymphoma]] is approximately 0.41/100,000.<ref name="pmid31640759">{{cite journal |vauthors=Zhou L, Deng Y, Li N, Zheng Y, Tian T, Zhai Z, Yang S, Hao Q, Wu Y, Song D, Zhang D, Lyu J, Dai Z |title=Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study |journal=J Hematol Oncol |volume=12 |issue=1 |pages=107 |date=October 2019 |pmid=31640759 |pmc=6805485 |doi=10.1186/s13045-019-0799-1 |url=}}</ref> | ||
===Age=== | ===Age=== | ||
[[Non-Hodgkin lymphoma]] (NHL) commonly affects individuals older than 65 years of age. However, some subtypes of NHL (i.e., [[Burkitt lymphoma]]) show a bimodal age distribution. [[Hodgkin's lymphoma]] has a bimodal age distribution with the highest incidence in patients (20-39) years of age and older than 60 years of age.<ref name="pmid31640759">{{cite journal |vauthors=Zhou L, Deng Y, Li N, Zheng Y, Tian T, Zhai Z, Yang S, Hao Q, Wu Y, Song D, Zhang D, Lyu J, Dai Z |title=Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study |journal=J Hematol Oncol |volume=12 |issue=1 |pages=107 |date=October 2019 |pmid=31640759 |pmc=6805485 |doi=10.1186/s13045-019-0799-1 |url=}}</ref> | |||
===Race=== | ===Race=== | ||
Revision as of 03:18, 17 February 2022
|
B-cell lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
B-cell lymphoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of B-cell lymphoma epidemiology and demographics |
|
Risk calculators and risk factors for B-cell lymphoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
Epidemiology and Demographics
Incidence
The incidence of non-Hodgkin lymphoma is approximately 18.6 per 100,000 individuals worldwide.[1] The incidence of Hodgkin's lymphoma is approximately 2-3 per 100,000 individuals in populations of European ancestry.[2]
Prevalence
Case-fatality rate/Mortality rate
In year 2018, the mortality rate of non-Hodgkin lymphoma is approximately 5.1/100,000.[1] In year 2017, the mortality rate of Hodgkin's lymphoma is approximately 0.41/100,000.[3]
Age
Non-Hodgkin lymphoma (NHL) commonly affects individuals older than 65 years of age. However, some subtypes of NHL (i.e., Burkitt lymphoma) show a bimodal age distribution. Hodgkin's lymphoma has a bimodal age distribution with the highest incidence in patients (20-39) years of age and older than 60 years of age.[3]
Race
Gender
Region
References
- ↑ 1.0 1.1 Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P (January 2021). "Epidemiology of Non-Hodgkin's Lymphoma". Med Sci (Basel). 9 (1). doi:10.3390/medsci9010005. PMC 7930980 Check
|pmc=value (help). PMID 33573146 Check|pmid=value (help). - ↑ Connors JM, Cozen W, Steidl C, Carbone A, Hoppe RT, Flechtner HH, Bartlett NL (July 2020). "Hodgkin lymphoma". Nat Rev Dis Primers. 6 (1): 61. doi:10.1038/s41572-020-0189-6. PMID 32703953 Check
|pmid=value (help). - ↑ 3.0 3.1 Zhou L, Deng Y, Li N, Zheng Y, Tian T, Zhai Z, Yang S, Hao Q, Wu Y, Song D, Zhang D, Lyu J, Dai Z (October 2019). "Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study". J Hematol Oncol. 12 (1): 107. doi:10.1186/s13045-019-0799-1. PMC 6805485 Check
|pmc=value (help). PMID 31640759.